Login
Home / XVIPY : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Xvivo Perfusion AB (publ)

$6.88 +$0.34 (+5.20%)
OTC · 02 Sep 2026 20:00 UTC
Previous Close
$7.4
Day Range
$6.88 - $6.88
Year Range
$4.25$8.18
Market Cap
866.87M
AVG Volume
553
Trailing/Forward PE
90.46/-
PEG ratio
1.23
Dividend Yield
-
Next Earnings Date
2026-10-22
Primary Exchange
Other OTCUS
Revenue (SEK)
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (SEK)
-25M025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (SEK)
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (SEK)
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (SEK)
-40M-20M020M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (SEK)
-0.200.20.40.60.824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (SEK)
050M100M150M200MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (SEK)
0200M400M600MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-3-2-1024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-2%0%2%4%6%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Book Value Per Share (SEK)
0510152024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (SEK)
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
0200400600800med 133.13Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
Free Cash Flow Yield
-1%-0.5%0%0.5%1%med 0.04%Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
Price to Sales
0102030med 17.28Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
EV/EBITDA
255075100125150med 75.05Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
Price/Operating Cashflow
050010001500med 211.03Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
Price to Book
246810med 4.8Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
Xvivo Perfusion AB (publ)
XVIPY
Stockpicker

Video analysis: XVIPY

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: XVIPY

Xvivo Perfusion AB (publ) (XVIPY) Q2 2026 Earnings Call Transcript

seekingalpha.com · 14 Jul 2026

Xvivo Perfusion AB (publ) (XVIPY) Q2 2026 Earnings Call Transcript

Xvivo Perfusion AB (publ) (XVIPY) Q2 2026 Earnings Call Transcript

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.